Subventions financées

The overarching aim of Ms Morena’s research is to investigate the role of the endocannabinoid system in the modulation of memory processes and its interaction with stress and emotional arousal in animal models of cognition, at a cellular, circuit and behavioural level.

The demonstration that mature somatic cells can be converted to new, heterologous cell types, now termed “cellular reprogramming”, led to the 2012 Nobel Prize in Physiology or Medicine, and sparked an explosion of studies investigating the therapeutic potential of such an approach.

The lifetime risk of developing amyotrophic lateral sclerosis (ALS) is approximately 1 in 350 for men and 1 in 440 for women, making it the most common adult-onset motor neuron disease.

Tumors continuously change towards more aggressive and resistant forms.

The prevalence of obesity has reached pandemic levels and represents a massive societal and economic burden.

Fetal growth restriction is associated with pregnancy complications, as well as high rates of preterm birth and childhood disabilities.

In 2017, Canada saw 89,500 new strokes in people aged 20 and older and counted 878,500 people living with stroke.

Brain-based disorders such as epilepsy, stroke, acquired brain injury, and Parkinson’s Disease impact tens of thousands of Canadians each year.

Injuries and diseases of the nervous system have devastating effects.

By the time a person receives a diagnosis of Alzheimer’s disease (AD) dementia, brain atrophy is such that memory impairments are irreversible.